Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective

VG Manolopoulos, G Ragia, A Tavridou - Pharmacogenomics, 2011 - Taylor & Francis
Type 2 diabetes mellitus (T2DM) is an increasingly prevalent disease. Several classes of
drugs are currently available to treat T2DM patients; however, clinical response to these …
被引用次数：87 相关文章

Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective

VG Manolopoulos, G Ragia… - …, 2011 - pubmed.ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is an increasingly prevalent disease. Several classes of
drugs are currently available to treat T2DM patients; however, clinical response to these …

Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective

VG Manolopoulos, G Ragia, A Tavridou - Pharmacogenomics, 2011 - search.proquest.com
Type 2 diabetes mellitus (T2DM) is an increasingly prevalent disease. Several classes of
drugs are currently available to treat T2DM patients; however, clinical response to these …

Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.

VG Manolopoulos, G Ragia, A Tavridou - Pharmacogenomics, 2011 - europepmc.org
Type 2 diabetes mellitus (T2DM) is an increasingly prevalent disease. Several classes of
drugs are currently available to treat T2DM patients; however, clinical response to these …

Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective

VG Manolopoulos, G Ragia, A Tavridou - Pharmacogenomics, 2011 - go.gale.com
Diabetes is an increasingly prevalent disease that has reached epidemic proportions.
According to the fourth edition of the Diabetes Atlas (October 2009), the estimated worldwide …